Teladoc Announces Second Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Teladoc (TDOC) PT Raised to $86 at Chardan Capital Markets
August 3, 2018 6:39 AM EDTChardan Capital Markets raised its price target on Teladoc (NYSE: TDOC) to $86.00 (from $73.00) while maintaining a Buy rating.
Analyst Steven Wardell commented, "After market close on Wed., TDOC reported revenue and earnings that beat "consensus, and raised its 2018 guide. TDOCs... More
Teladoc (TDOC) PT Raised to $68 at Oppenheimer
August 2, 2018 9:32 AM EDTOppenheimer raised its price target on Teladoc (NYSE: TDOC) to $68.00 (from $59.00) while maintaining a Outperform rating.
Analyst Mohan Naidu commented, "Teladoc Health (as the company has renamed itself) beat our and consensus expectations for revenues and EBITDA at $95M/$2.7M... More
Teladoc (TDOC) PT Raised to $52 at Cantor Fitzgerald Following 2Q
August 2, 2018 8:21 AM EDTCantor Fitzgerald raised its price target on Teladoc (NYSE: TDOC) to $52.00 (from $50.00) while maintaining a Neutral rating following the company's 2Q release. Revenue was $94.6 million vs. consensus of $92M. U.S. paid visits grew 41%.
Given the strong growth and including Advance Medical, TDOC... More
Teladoc (TDOC) PT Raised to $77 at Piper Jaffray Following 2Q Report
August 2, 2018 7:13 AM EDTPiper Jaffray raised its price target on Teladoc (NYSE: TDOC) to $77.00 (from $55.00) while maintaining an Overweight rating following the company's 2Q earnings report. Total revenue of $94.6M was up 112% on an absolute basis and 39% organically, and beat Consensus estimates of $91.9M. EBITDA of... More
